Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Plos One
|
January 18, 2022
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment
Kenji Yamaoka, Kenichiro Kodama, Tomokazu Kawaoka, et al.
BMC Gastroenterology
|
June 2, 2022
Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study
Kensuke Naruto, Tomokazu Kawaoka, Kenichiro Kodama, et al.
International Journal of Clinical Oncology
|
January 25, 2020
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
Yoichi Naito, Saori Mishima, Kiwamu Akagi, et al.
BMC Gastroenterology
|
June 28, 2023
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study
Yusuke Johira, Takashi Nakahara, Takahiro Kinami, et al.
Nature Medicine
|
November 12, 2021
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial
Yoshiaki Nakamura, Wataru Okamoto, Takeshi Kato, et al.
Medicine
|
October 22, 2021
Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
Shigeki Yano, Tomokazu Kawaoka, Yusuke Johira, et al.
International Journal of Cancer
|
September 2, 2022
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma
Peiyi Zhang, Atsushi Ono, Yasutoshi Fujii, et al.
Japanese Journal of Clinical Oncology
|
October 29, 2023
Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study
Takafumi Fukushima, Keisuke Goto, Tetsutaro Hayashi, et al.
Cancers
|
September 9, 2023
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment
Yosuke Tamura, Atsushi Ono, Hikaru Nakahara, et al.
International Journal of Clinical Oncology
|
May 22, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
Yoichi Naito, Saori Mishima, Kiwamu Akagi, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Plos One
|
January 18, 2022
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment
Kenji Yamaoka, Kenichiro Kodama, Tomokazu Kawaoka, et al.
BMC Gastroenterology
|
June 2, 2022
Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study
Kensuke Naruto, Tomokazu Kawaoka, Kenichiro Kodama, et al.
International Journal of Clinical Oncology
|
January 25, 2020
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
Yoichi Naito, Saori Mishima, Kiwamu Akagi, et al.
BMC Gastroenterology
|
June 28, 2023
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study
Yusuke Johira, Takashi Nakahara, Takahiro Kinami, et al.
Nature Medicine
|
November 12, 2021
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial
Yoshiaki Nakamura, Wataru Okamoto, Takeshi Kato, et al.
Medicine
|
October 22, 2021
Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
Shigeki Yano, Tomokazu Kawaoka, Yusuke Johira, et al.
International Journal of Cancer
|
September 2, 2022
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma
Peiyi Zhang, Atsushi Ono, Yasutoshi Fujii, et al.
Japanese Journal of Clinical Oncology
|
October 29, 2023
Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study
Takafumi Fukushima, Keisuke Goto, Tetsutaro Hayashi, et al.
Cancers
|
September 9, 2023
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment
Yosuke Tamura, Atsushi Ono, Hikaru Nakahara, et al.
International Journal of Clinical Oncology
|
May 22, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
Yoichi Naito, Saori Mishima, Kiwamu Akagi, et al.
Page
of 10